Recent news on Adefovir

BARACLUDE(R) Treatment Demonstrated Greater Viral Load Reduction ...  -  May 22, 2007
Medical News Today (press release),Study ETV-079 evaluated the antiviral activity of BARACLUDE and adefovir, and enrolled patients who had a high viral load at study entry (HBV DNA greater

Baraclude Treatment Demonstrated Great Viral Load Reduction  -  May 22, 2007
eMaxHealth.com,Bristol-Myers Squibb announced that treatment with BARACLUDE (entecavir) demonstrated greater viral load reduction than adefovir at 48 weeks -- a result

Market Report -- In Play (BMY)  -  May 21, 2007
MSN MoneyBristol-Myers says Baraclude treatment demonstrated greater viral load reduction compared to Adefovir at 48 weeks Co announces new data from study ETV-079,

DMCH doc attends international conference on liver diseases  -  May 1, 2007
Ludhiana Newsline,Newly introduced anti-viral drugs like adefovir, entecavir and teluvidine are available presently for management of Hepatitis B. According to specialists,

Sebivo(R) (Telbivudine) Approved In European Union As A New ...  -  May 1, 2007
Medical News Today (press release),There are no adequate and well-controlled studies for telbivudine treatment of patients with established lamivudine-resistant or adefovir-resistant

Lamivudine-Resistant Hepatitis B Patients Achieve Sustained ...  -  Apr 17, 2007
DG NewsBARCELONA, SPAIN -- April 17, 2007 -- Long-term treatment with adefovir dipivoxil and lamivudine decreases the risk of genotypical resistance to adefovir in

Adefovir And Lamivudine Combo Is Effective In Lamivudine-Resistant ...  -  Apr 16, 2007
Medical News Today (press release),Long-term treatment with adefovir dipivoxil (ADV, HepseraR) and lamivudine provides multiple benefits in lamivudine-resistant patients with chronic

SEBIVO® Demonstrated Better Antiviral Activity Compared to ...  -  Apr 13, 2007
EndoNurse,It is associated with better treatment outcomes at one year, and SEBIVO achieved this goal better than adefovir." These new findings come from a trial

SEBIVO(R) Demonstrated Better Antiviral Activity Compared to ...  -  Apr 13, 2007
FinanzNachrichten.de,In a comparative study, SEBIVO(R) (telbivudine) provided more rapid and profound viral suppression than adefovir both in newly diagnosed HBeAg- positive

Idenix (IDIX) Said SEBIVO Demonstrated Better Antiviral Activity ...  -  Apr 13, 2007
StreetInsider.com (subscription),Idenix Pharmaceuticals Inc. (Nasdaq: IDIX) said, in a comparative study, SEBIVO provided more rapid and profound viral suppression than adefovir both in

Idenix Announces Thirteen Data Presentations at the 2007 European ...  -  Apr 12, 2007
Drug Newswire (press release),Dr. Marcellin will also present "In Hepatitis B Patients Treated with Either Adefovir or Telbivudine, Maximal Early HBV Suppression at 24 Weeks Predicts

ANA380 Exhibits Activity In Vitro Against Multiple Clinically ...  -  Apr 13, 2007
Earthtimes.orgThe study found that the in vitro antiviral potency of ANA380 against seven of nine mutants that were resistant to lamivudine, adefovir, entecavir or

Anadys Pharmaceuticals (ANDS) Higher After Positive Study Results  -  Apr 13, 2007
StreetInsider.com (subscription),The company said the study found that the in vitro antiviral potency of ANA380 against seven of nine mutants that were resistant to lamivudine, adefovir,

Anadys Pharma Reports ANA380 Exhibits Activity In Vitro Against ...  -  Apr 13, 2007
Trading Markets,...retains potency against multiple mutant strains of hepatitis B virus or HBV which are resistant to lamivudine, adefovir, entecavir or telbivudine.

ANA380 Exhibits Activity In Vitro Against Multiple Clinically ...  -  Apr 13, 2007
PR-Inside.com (Pressemitteilung),...of ANA380 against seven of nine mutants that were resistant to lamivudine, adefovir, entecavir or telbivudine was not significantly different from the

Idenix Announces Data Presentations at the 2007 Digestive Disease ...  -  Apr 19, 2007
PharmaLive.com (press release),Adefovir for HBeAg-Positive Chronic Hepatitis B: Efficacy Through Week 76, Predictors of Response and Effects of Switching to Telbivudine" in a poster

Gilead's Atripla, Lower Costs Provide Lift To First Quarter  -  Apr 22, 2007
BioWorld Online,Hepsera (adefovir dipivoxil), for chronic hepatitis B, and AmBisome (amphotericin B), the liposome-for-injection therapy for severe fungal infections,

Fresh from the Pipeline: Telbivudine  -  Apr 5, 2007
Nature.com (subscription),It has since been joined on the market by the nucleotide analogue adefovir dipivoxil (Hepsera; Gilead) and the nucleoside analogues entecavir (Baraclude;

Gilead Sciences Announces First Quarter 2007 Financial Results  -  Apr 19, 2007
PharmaLive.com (press release),Hepsera(R) (adefovir dipivoxil) and AmBisome(R) (amphotericin B) liposome for injection also experienced solid sales growth compared to the same quarter

Gilead Sciences Announces First Quarter 2007 Financial Results  -  Apr 18, 2007
Business Wire (press release),Hepsera ® (adefovir dipivoxil) and AmBisome ® (amphotericin B) liposome for injection also experienced solid sales growth compared to the same quarter last

StreetInsider.com Pre-Open Movers 04/13  -  Apr 13, 2007
StreetInsider.com (subscription),...retains potency against multiple mutant strains of hepatitis B virus (HBV) which are resistant to lamivudine, adefovir, entecavir or telbivudine

Gilead Sciences: Rapid Growth Expected From New Products  -  Apr 3, 2007
Seeking Alpha,...of Truvada (emtricitabine and tenofovir disoproxil fumarate) and Viread (tenofovir disoproxil fumarate), as well as Hepsera (adefovir dipivoxil).

Idenix Announces Thirteen Data Presentations at the 2007 European ...  -  Mar 1, 2007
PR Newswire (press release),Dr. Marcellin will also present "In Hepatitis B Patients Treated with Either Adefovir or Telbivudine, Maximal Early HBV Suppression at 24 Weeks Predicts

Metabasis Therapeutics Reports on 2006 Financial Results and ...  -  Mar 9, 2007
PharmaLive.com (press release),Importantly, pradefovir treatment at this dose resulted in circulating levels of adefovir that were lower than was seen with the approved dose of Hepsera.

BC likened to US after refusal to pay for costly treatment  -  Mar 22, 2007
Globe and Mail,About 350 BC residents are currently receiving Adefovir dipivoxil, marketed as Hepsera, for free, but those giveaways will come to an end by July.

Refusal to pay for drug sparks outrage in BC  -  Mar 21, 2007
Globe and Mail,Adefovir dipivoxil, marketed as Hepsera, costs about five times more than a drug approved by the provincial pharmacare program, but it is far more effective

Factor V; Hepatitis B  -  Mar 14, 2007
Sarasota Herald-Tribune,Medicines for hepatitis B are entecavir, adefovir, lamivudine and interferon alpha. The newest medicine is telbivudine.

Anti-HBV drug entecavir also active against HIV and promotes ...  -  Mar 1, 2007
Aidsmap,Two agents currently approved for the treatment of hepatitis B virus (HBV) infection – lamivudine (3TC; Epivir-HBV) and adefovir (Hepsera) also demonstrate

Long-term adefovir therapy useful for chronic hepatitis B  -  Jan 30, 2007
Therapeutics Daily (subscription) (press release),NEW YORK (Reuters Health) - Treatment with adefovir dipivoxil for up to 5 years is well tolerated and provides a variety of benefits for patients with

Gilead Sciences Announces Fourth Quarter and Full Year 2006 ...  -  Feb 1, 2007
PharmaLive.com (press release),Truvada(R) (emtricitabine and tenofovir disoproxil fumarate) and Viread(R) (tenofovir disoproxil fumarate), as well as Hepsera(R) (adefovir dipivoxil).

Gilead Sciences Announces Fourth Quarter and Full Year 2006 ...  -  Jan 31, 2007
Business Wire (press release),...of Truvada ® (emtricitabine and tenofovir disoproxil fumarate) and Viread ® (tenofovir disoproxil fumarate), as well as Hepsera ® (adefovir dipivoxil).

Clinical Advances in Hepatitis B and Hepatitis C  -  Dec 6, 2006
Medscape (subscription)Adefovir is a nucleotide analog with effective antiviral activity against the lamivudine-resistant YMDD viral strain. Previously, once resistance had

(Datamonitor insight into the Chinese Hepatitis B & C market)  -  Dec 18, 2006
Biotecheast.com,...therapies a gold standard, although lamivudine is the most prescribed first-line therapy, while adefovir is the most prescribed second-line therapy.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional